Author Correction: Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP

Affiliations

¹ Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.
² Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
³ Department of Chemistry, Washington University in St Louis, St Louis, MO, USA.
⁴ Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
⁵ Department of Parasitology, University of Sao Paulo, Sao Paulo, Brazil.
⁶ Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia.
⁷ Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁸ Department of Global Health, College of Public Health, University of South Florida, Tampa, FL, USA.
⁹ Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA. niraj.tolia@nih.gov.
¹⁰ Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. niraj.tolia@nih.gov.

Published Erratum

Darya Urusova et al. Nat Microbiol. 2019 Nov.

. 2019 Nov;4(11):2024.

doi: 10.1038/s41564-019-0587-2.

¹ Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA.
² Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
³ Department of Chemistry, Washington University in St Louis, St Louis, MO, USA.
⁴ Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
⁵ Department of Parasitology, University of Sao Paulo, Sao Paulo, Brazil.
⁶ Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia.
⁷ Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁸ Department of Global Health, College of Public Health, University of South Florida, Tampa, FL, USA.
⁹ Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA. niraj.tolia@nih.gov.
¹⁰ Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. niraj.tolia@nih.gov.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.
Urusova D, Carias L, Huang Y, Nicolete VC, Popovici J, Roesch C, Salinas ND, Dechavanne S, Witkowski B, Ferreira MU, Adams JH, Gross ML, King CL, Tolia NH. Urusova D, et al. Nat Microbiol. 2019 Sep;4(9):1486-1496. doi: 10.1038/s41564-019-0461-2. Epub 2019 May 27. Nat Microbiol. 2019. PMID: 31133752 Free PMC article.